Lack of induction of interleukin-2-receptor-alpha in patients with tuberculosis and human immunodeficiency virus co-infection: implications for pathogenesis.

[1]  R. Lal,et al.  Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and β2‐microglobulin, respectively , 2000, Clinical and experimental immunology.

[2]  S. Lawn,et al.  Elevated serum concentrations of soluble CD14 in HIV− and HIV+ patients with tuberculosis in Africa: prolonged elevation during anti‐tuberculosis treatment , 2000, Clinical and experimental immunology.

[3]  S. Lawn,et al.  Pulmonary tuberculosis: radiological features in west Africans coinfected with HIV. , 1999, The British journal of radiology.

[4]  K. Smith,et al.  Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  N. Mehra,et al.  Correlation of serum interleukin-2 receptor-alpha levels with clinical manifestations in pulmonary tuberculosis. , 1996, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  W. Rom,et al.  Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. , 1996, American journal of respiratory and critical care medicine.

[7]  K. D. de Cock,et al.  Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire , 1995, The Lancet.

[8]  R. Hayes,et al.  The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia. , 1993, The Journal of tropical medicine and hygiene.

[9]  J. Habeshaw,et al.  HIV‐induced deletion of antigen‐specific T cell function is MHC restricted , 1992, Clinical and experimental immunology.

[10]  R. Detels,et al.  Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV infection: distinctive parameters of HIV-induced change. , 1991, Clinical immunology and immunopathology.

[11]  T. Waldmann,et al.  The interleukin-2 receptor. , 1991, The Journal of biological chemistry.

[12]  S. Kira,et al.  Soluble lnterleukin-2 Receptor in Sera of Patients with Pulmonary Tuberculosis , 1991 .

[13]  W. Greene,et al.  The molecular basis for the generation of the human soluble interleukin 2 receptor. , 1990, Cytokine.

[14]  N. Chirmule,et al.  Human immunodeficiency virus type 1 envelope glycoprotein gp 120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Clerici,et al.  Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. , 1989, The Journal of clinical investigation.

[16]  Webster Hk,et al.  Prolonged elevations of soluble interleukin-2 receptors in tuberculosis. , 1989 .

[17]  A. Dannenberg.  Immune mechanisms in the pathogenesis of pulmonary tuberculosis. , 1989, Reviews of infectious diseases.

[18]  Kendall A. Smith,et al.  Interleukin-2: inception, impact, and implications. , 1988, Science.

[19]  J. Fahey,et al.  Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. , 1987, Journal of immunology.

[20]  J. Hoxie,et al.  Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. , 1986, Science.

[21]  T. Waldmann.  The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. , 1986, Science.

[22]  D. Nelson,et al.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. , 1985, Journal of immunology.

[23]  T. Waldmann,et al.  Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. , 1985, The New England journal of medicine.

[24]  S. Lucas,et al.  Données fournies par l'autopsie de 70 sujets décédés de SIDA en milieu pneumologique ivoirien : impact de la tuberculose , 1995 .

[25]  R. Puri,et al.  Constitutive expression of human immunodeficiency virus type 1 tat gene inhibits interleukin 2 and interleukin 2 receptor expression in a human CD4+ T lymphoid (H9) cell line. , 1995, AIDS research and human retroviruses.

[26]  K. D. de Cock,et al.  [Autopsy findings in 70 AIDS patients who died in a department of pneumology in Ivory Coast: impact of tuberculosis]. , 1995, Medecine tropicale : revue du Corps de sante colonial.

[27]  J. Carlin,et al.  Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. , 1991, Journal of acquired immune deficiency syndromes.

[28]  A. Fauci,et al.  The immunopathogenesis of HIV infection. , 1989, Advances in immunology.